ChemMedChem · 2016 · 28 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntibacterial PharmacologyEnzyme InhibitionNatural Product Drug DiscoveryAntibacterial Drug DevelopmentAntibiotic DiscoveryAntimicrobial Drug DevelopmentNovel Antibacterial Drug DiscoveryPeptide Structure-activity RelationshipsPlant - Bacterium InteractionsStructure-based Lead DiscoveryStructure-guided Lead Discovery
The peptide antibiotic albicidin, which is synthesized by the plant pathogenic bacterium, Xanthomonas albilineans, represents the most prominent member of a new class of antibacterial gyrase inhibitors. It shows remarkable antibacterial activities against Gram-positive and Gram-negative microorganisms. Its unique structure potentially represents a new lead structure for the development of an antibacterial drug. Here we report the synthesis of 14 albicidin derivatives with structural variations at the N-terminus, primarily investigating the effects of variation of cinnamoyl, phenylpropanoyl, and benzoyl residues. Gyrase inhibition in vitro and determination of minimal inhibitory concentrations were assessed in parallel. Activities in a nanomolar range and the importance of N-acylation were demonstrated.
15
Helen W. Boucher, George H. Talbot, Daniel K. Benjamin et al. · Clinical Infectious Diseases · 2013 · 696 citations · Full text
The Phytotoxin Albicidin is a Novel Inhibitor of DNA Gyrase
Saeed M. Hashimi, Melisa K. Wall, Andrew Smith et al. · Antimicrobial Agents and Chemotherapy · 2006 · 130 citations · Full text